About MBT
First-in-class oncology medicines targeting human kinome.

Scientific Advisory Board

Prof. Si Young Song

Experience & Education
  • Professor, Yonsei University College of Medicine
  • President, Korean Society of Pancreatic Biliary Tract
  • President, Korean Society of Biomedical Engineering
  • President and Chairman of the Korean Society of Digestive Cancer
  • Doctor of Medicine, Yonsei University
Significant Research Achievements
  • 350 SCI papers, 27 patents
  • Pancreatic cancer, biliary tract cancer chemotherapy, cancer stem cells, tumor biology

Prof. Han Sang Kim

Experience & Education
  • Professor, Department of Internal Medicine, Yonsei University College of Medicine
  • Ph.D., Yonsei University
Significant Research Achievements
  • 40 SCI papers, 7 patents
  • Exosome, Cancer Metastasis, Pre-metastatic niche
  • Clinical research on the latest targeted anticancer drugs, immuno-oncology drugs, and new drugs for colorectal cancer and liver cancer

Prof. Young Tae Chang

Experience & Education
  • Professor, New York University
  • Professor, National University of Singapore
  • Head, A-Star SBIC Probe Research Team
  • Vice president, Institute for basic science (IBS)
  • Member of the National Academy of science
  • Pohang University of Science and Technology, Ph.D.
Significant Research Achievements
  • 380 SCI papers, > 50 patents
  • Development of > 30 types of pharmaceutical sensors
  • First introduction and establishment of fluorescence library concept
  • Development of cancer stem cell probe
  • Development of live cell selective imaging probe